Abstract
The standardized maritime pine bark extract (Pycnogenol ®) was reported to exert clinical anti-diabetic effects after peroral intake. However, an increased insulin secretion was not observed after administration of the extract to patients. Our aim was to elucidate whether the described clinical effects of Pycnogenol ® are related to inhibition of α-glucosidase. Therefore, we analyzed the inhibitory activity of Pycnogenol ®, green tea extract and acarbose towards α-glucosidase. Furthermore, we explored different fractions of Pycnogenol ® containing compounds of diverse molecular masses from polyphenolic monomers, dimers and higher oligomers to uncover which components exhibited the most pronounced inhibitory activity. We found that Pycnogenol ® exhibited the most potent inhibition (IC 50 about 5 μg/mL) on α-glucosidase compared to green tea extract (IC 50 about 20 μg/mL) and acarbose (IC 50 about 1 mg/mL). The inhibitory action of Pycnogenol ® was stronger in extract fractions containing higher procyanidin oligomers. The results obtained assign a novel, local effect to oligomeric procyanidins and contribute to the explanation of glucose-lowering effects of Pycnogenol ® observed in clinical trials with diabetic patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
